AzTrials
AzTrials

Working Memory DeficitsNEPANCT02824588

Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain

A study testing Working Memory Training and Internet use in people with Working Memory Deficits and Neuropathic Pain, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. Read more about this study

Who is it for?
Ages 18 to 69 years
What is being tested?
Working Memory Training and Internet use
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteNorway
Study dates
Sep 2016to 2 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 69 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Confirmed diagnosis of fibromyalgia or neuropathic pain
  • Confirmed objective cognitive impairments on the CANTAB battery compared to IQ control

Who cannot join

  • Mania, suicidal ideation and/or active psychosis
  • No objective cognitive impairments
  • Personality disorders
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University Hospital

    Oslo, 0450

Other trials in Norway

About this study

Official title: Executive Control, Processing Speed and Memory Function in Long- Term Peripheral Neuropathic Pain and Fibromyalgia

The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. It is also hypothesized that all participants with poor executive control functioning will report significant improvements in pain intensity, functioning and cognitive complaints following cognitive training. The study tests and influence the working memory concepts of inhibition, updating and flexibility through an experimental, cross-over treatment design.

To perform the experiment, we will recruit 160 participants (80 with neuropathic pain and 80 with FM) from the Departments of pain management and research at St Olav's University Hospital and Oslo University Hospital (OUS). The proposed design will be able to determine whether or not executive control, processing speed and memory function differs in two distinct populations of pain patients. Moreover, whether impairments are amended by computerized training.

Being tested
Working Memory Training, Internet use
Keywords
Pain, Working memory
Medical subject headings
Neuralgia, Fibromyalgia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Working Memory TrainingBehavioural

    Training mental flexibility

  • Internet useBehavioural

    Used as control for time spent on computer

Study groups in NCT02824588
Study groupRoleWhat they receive
InterventionExperimentalWorking Memory Training
Receives: Behavioral: Working Memory Training
ControlActive comparatorInternet use
Receives: Behavioral: Internet use

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective neuropsychological tests

    CANTAB test battery

    Measured: 36 weeks

Secondary outcomes (8)
  1. Pain intensity

    VAS scale

    Measured: 36 weeks

  2. Stress regulation

    Hair cortisol

    Measured: 36 weeks

  3. Symptoms of depression

    Hopkins symptom checklist

    Measured: 36 weeks

  4. Sleep duration, quality and awakening

    Actigraphy

    Measured: 36 weeks

  5. Quality of life

    EQ-5D

    Measured: 36 weeks

  6. Medication use

    Registered analgetic usage

    Measured: 36 weeks

  7. Self-reported memory and concentration impairments

    Everyday Memory Questionnaire

    Measured: 36 weeks

  8. Self-reported cognitive intrusion

    Questionnaire

    Measured: 36 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2016 (estimated)
  2. Study startSep 2016
  3. Primary completion2 Sep 2018
  4. Study completion2 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02824588
Sponsor's protocol ID
2016/8442
Acronym
NEPA
Status last verified
Sep 2018
First submitted
27 Jun 2016
Last updated
5 Sep 2018
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Working Memory Training and Internet use in people with Working Memory Deficits and Neuropathic Pain, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective neuropsychological tests (time frame: 36 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in